lung cancer

Coreline Soft's flagship product, AVIEW LCS, an AI-powered automatic pulmonary nodule analysis solution
By  Adam Ang 10:34 pm March 8, 2023
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules. The company develops AI imaging solutions for diagnosing various chest conditions, aortic disease, spinal disease, and metastatic cancer in the chest.  WHAT IT DOES Its latest software-as-a-medical device...
Dozee smart connected bed
By  Adam Ang 12:56 am December 23, 2022
Dozee scores 510(k) for AI contactless sensor for RPM Indian medical device company Dozee has received the United States Food and Drug Administration's 510(k) clearance for its proprietary contactless sensor for remote patient monitoring. The Dozee sensor sheet, which is placed under a hospital bed mattress, captures micro-vibrations from patients using Ballistocardiography. These vibrations are...
Babylon,
By  Tammy Lovell 11:56 am May 19, 2022
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group. The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
Qure.ai, AstraZeneca
By  Sara Mageit 09:53 am December 8, 2020
Global biopharmaceutical company, AstraZeneca has announced a partnership through its Emerging Markets Health Innovation Hubs programme, with India-based AI solution provider, Qure.ai. The partnership aims to to integrate AI solutions for the early detection of lung cancer in patients across AstraZeneca’s Emerging Markets regions, covering Latin America, Asia and the Middle East & Africa. WHY...
By  Dave Muoio 04:21 pm September 22, 2017
Early adopters left behind on Apple Watch. The upcoming Apple watchOS 4 may be overhauling the wearable’s heart rate detection capabilities, but those who picked up the smartwatch when it first launched in 2015 will have to make due without the added health and fitness features. The Verge attributes this divide to the faster hardware and larger batteries of the Series 1, 2, and 3 watches, which...
By  Brian Dolan 12:50 pm February 25, 2009
A UK nanotech company reportedly developed a mobile phone prototype with Nokia that can detect various diseases or medical conditions from a user's breath. The company, Applied Nanodetectors, claims the device can detect asthma, diabetes, lung cancer, breath odor, breath alcohol concentration and a certain type of food poisoning, according to Nikkei Electronics. The company demoed its prototype...